Cartalax (20 mg vial)
Once daily subcutaneous protocol for longevity and cellular health research.
Cartalax is a short Khavinson bioregulator peptide associated with cartilage and connective tissue in the Russian bioregulation literature. Western trial data does not exist. The protocol below is the traditional course format.
Quick answer: at the standard 20 mg + 2 mL reconstitution, a 5 mg dose of Cartalax draws 50 units (0.5 mL) on a U-100 insulin syringe, once daily subcutaneous.
Protocol overview
Dosing & reconstitution
Frequency: Once daily subcutaneous
Typical duration: 8-12 weeks
Reconstitution: 20 mg vial + 2 mL bacteriostatic water = 10 mg/mL. Units below are for a U-100 insulin syringe at this concentration.
| Phase | Dose | Units per injection |
|---|---|---|
| Weeks 1-2 | 2 mg | 20 units (0.2 mL) |
| Weeks 3-4 | 3 mg | 30 units (0.3 mL) |
| Weeks 5-8 | 4 mg | 40 units (0.4 mL) |
| Weeks 9-12 | 5 mg | 50 units (0.5 mL) |
Units = (dose ÷ concentration) × 100 on a U-100 syringe. Change the vial size or water volume and the calculator redoes all of this for you.
Track this protocol → Free account · log doses, rotate sites, never lose your history
Cartalax dosing — what the literature actually supports
We publish a schedule when there is a citable human source and we say so when there is not. Filling this space with a number nobody measured would make the page look more complete and be worth less than nothing to you.
Reconstitution and measurement
This part is arithmetic and does not depend on the evidence level. Concentration is vial size divided by the bacteriostatic water you add. Draw volume is your target amount divided by that concentration. Units are draw volume times 100, because a U-100 syringe reads 100 units per millilitre. Common vials for Cartalax: Not stocked by our featured supplier.
- Wipe the stoppers of both vials with an alcohol swab and let them dry.
- Draw the bacteriostatic water with a sterile syringe and inject it slowly down the inside wall of the peptide vial — never straight onto the powder.
- Swirl gently until the solution is clear. Do not shake; foaming and agitation damage peptides.
- Label the vial with the date and concentration, and refrigerate at 2–8 °C protected from light.
Storage and stability
Important notes
Practical considerations for consistency and safety.
- Use a new sterile insulin syringe for each injection and dispose in a proper sharps container.
- Inject slowly and steadily; wait a few seconds before withdrawing the needle to ensure complete delivery.
- Administer at the same time each day for consistent levels. Setting a daily reminder helps maintain the schedule.
- This compound lacks controlled human safety data. Start with the lowest reported amount and increase gradually while monitoring for any adverse reactions.
- The 20 mg vial size is standard for this compound. Reconstitute with 2 mL bacteriostatic water for a convenient concentration.
How Cartalax works
A short synthetic peptide from the Khavinson bioregulator series, associated in that literature with cartilage and connective tissue.
Benefits & side effects
Potential benefits
- Cartilage bioregulator (Khavinson peptide)
- Supports joint and connective tissue health
- Regulatory peptide from bioregulation research
- Well-tolerated in reported use
Possible side effects
- Injection site reactions
- Limited Western safety data
- Generally well tolerated in Russian research
- Bioregulator peptide
This list reflects published literature and community reports. Individual responses vary. Not medical advice.
Bloodwork worth tracking
The community-standard practice is a baseline panel before starting, a recheck 8 to 12 weeks in, and another after time off. For Cartalax, the markers most worth watching:
CMPCBC
Typical time off: 4-8 wks
Lab panels are how a research protocol stays honest: numbers move before symptoms do. Interpretation belongs with a clinician. Not medical advice.
Lifestyle factors
None of the literature above was run on a background of poor sleep and no protein. These variables move outcomes more reliably than any compound on this site.
- Protein in the 1.6 to 2.2 g/kg range preserves lean mass through any body-composition phase.
- Resistance training 2 to 4 days per week plus 150+ minutes of weekly aerobic work reinforces whatever the protocol is doing.
- Sleep is the recovery window: 7 to 9 hours at consistent times.
- Hydration matters more than usual on compounds with GI or flushing effects: 2 to 3 liters daily.
- Track the variables that matter: weigh-ins, measurements, photos, and labs at sensible intervals.
Quick answers
How many syringe units is a 5 mg dose of Cartalax?
At the standard reconstitution of 20 mg with 2 mL bacteriostatic water (10 mg/mL), a 5 mg dose draws 50 units (0.5 mL) on a U-100 insulin syringe.
How do you reconstitute Cartalax?
Add 2 mL of bacteriostatic water to the 20 mg vial for 10 mg/mL. Inject the water slowly down the inside wall of the vial, swirl gently without shaking, and refrigerate at 2 to 8 °C after mixing.
How long does a 20 mg vial of Cartalax last?
About 4 maintenance doses of 5 mg, roughly 0.6 weeks at once daily subcutaneous.
Does Cartalax have human trial data?
No published dosing literature exists for Cartalax. The amounts shown are community convention only.
How does Cartalax work?
A short synthetic peptide from the Khavinson bioregulator series, associated in that literature with cartilage and connective tissue.
Sourcing Cartalax
Our featured supplier does not stock this compound, and we are not going to point you at a vendor we have not looked at. Use the COA checklist on whoever you do buy from, and check the batch number on the certificate against the vial you receive.
